Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers

A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with traditional radiation therapy (IMRT).

Continue Reading

News Source: medicalxpress.com